Diligence memo · auto-generated · as of July 2, 2026
BTB Therapeutics, Inc.
BTB Therapeutics, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
BTB Therapeutics, Inc. operates in Pharmaceuticals, based in ESCONDIDO.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BTB Therapeutics, Inc. has raised $6.7M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.4M on 2025-11-14.
Most recent recorded round closed around 2025-11-14.
Valuation (modeled)modeled
Provath models BTB Therapeutics, Inc. at approximately $7.9M (range $2.6M–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.30× the median modeled value of Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era. Within the normal band (130% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 8 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 47% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 14% of those peers.
Closest niche peers: Kairos Pharma, LTD., Branch Therapeutics, Inc., ResBiotic Nutrition, Inc., Califia Pharma, Inc., Avana Health, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.